- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04626804
Remember Stuff: A Dyadic-focused Technology to Support Persons With Alzheimer's Disease in the Community (R/S)
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46022
- Indiana University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Patient Inclusion Criteria:
- achieve a Montreal Cognitive Assessment (MoCA) score of 6-17 (mild to moderate dementia)
- diagnosis of early Alzheimer's disease or related dementia or caregiver reports ADRD diagnosis (if community based recruitment)
- provide identification of a caregiver (living with or otherwise involved in the ongoing care of the person with ADRD)
- able to communicate in English
- able to provide informed consent
Patient Exclusion Criteria:
- lives in a nursing home or long term care facility or assisted living facility
- do not pass the MoCA with a score between 6-17
- unable to identify a caregiver
- is limited by severe arthritis or other condition in the use of his/her hands
Caregiver Inclusion Criteria:
- 21 years or older
- able to provide informed consent
- able to communicate in English
Caregiver Exclusion Criteria:
- under 21 years of age
- does not have access to a computer/device
- diagnosis of ADRD
- diagnosis of serious mental illness (i.e. schizophrenia)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1 Test the usability, perceptions, and acceptability of R/S
Dyads will use the R/S unit for 90 days, unless they request it to be removed prior to the end of the study. .
The primary outcome is a caregiver-assessed measure usability.
|
testing the usability, perceptions, and acceptability of R/S among dyads of older adults with early Alzheimer's disease and other related dementias
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Usability
Time Frame: through study completion, an average of 4 months
|
Satisfaction and use of the monitor and apps using the Usability Scale, a validated 10-item scale sithe items suchs as "learning to use the calendar function was quick for me", using a 5 point response scale (0= strongly disagree to 5= strongly agree) Usability Scale, a validated 10-item scale (e.g. "Learning to use Calendar function was quick for me" using a 5-point response scale (0=strongly disagree to 5= strongly agree) |
through study completion, an average of 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability
Time Frame: through study completion, an average of 4 months
|
Acceptability satisfaction assessed by the VAS using a 3-item score: participants willingness to use "Assuming I have access to this technology today, I would use it".
Participants' willingness to use in the future "I could imagine using this technology in the future".
Perceived usefulness scale -Using this technology would be a relief for my daily care routine.
"Altogether I think this technology would be useful in my daily care routine.
Perecived ease of use scale- Interacting with the technology would not require a lot of mental effort "I think I would have the technology under control- Altogether I think the technology would be easy to use".
|
through study completion, an average of 4 months
|
|
Intention of Use
Time Frame: through study completion, an average of 4 months
|
The Behavioral Intention scale (e.g., "If it were up to you, to what extent would you want to use RememberStuff®?").
The 4-item scale uses a 7-point response scale from 0 (not at all) to 6 (a great deal).
Behavioral intention is the canonical assessment for user acceptance of technology
|
through study completion, an average of 4 months
|
|
Performance expectancy
Time Frame: through study completion, an average of 4 months
|
7 items (e.g.
"Thinking about using RememberStuff® in the past 90 days, to what extent do you find it useful in your daily life?") that use a 7-point response scale from 0 (not at all) to 6 (a great deal).
3-5 Semi-structured and open-ended questions about experience using the technology.
|
through study completion, an average of 4 months
|
|
Computer literacy
Time Frame: through study completion, an average of 4 months
|
The Computer Literacy Scale for Older Adults-12 (CLS-12)24 is a validated measure that assess frequency of 11 different computer related tasks including knowledge of symbols, terms related to computers and electronic devices, and internet use
|
through study completion, an average of 4 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dementia Severity Scale
Time Frame: through study completion, an average of 4 month
|
validated tool measuring dementia severity at specific intervals of the study
|
through study completion, an average of 4 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006294326
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Remember Stuff: A Dyadic-focused Technology to Support Persons with Alzheimer's Disease in the Community
-
Assistance Publique - Hôpitaux de ParisRecruiting